DELTASONE (nda009986)- (2.5MG,5MG,10MG,20MG,50MG)

Generic Name	PREDNISONE	Innovator	PHARMACIA AND UPJOHN
Dosage	2.5MG,5MG,10MG,20MG,50MG
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	Expired	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	DELTASONE Tablets are indicated in the following conditions: Endocrine Disorders, Rheumatic Disorders, Collagen Diseases, Dermatologic Diseases, Allergic States, Ophthalmic Diseases, Respiratory Diseases, Hematologic Disorders, Neoplastic Diseases, Edematous States, Gastrointestinal Diseases, Nervous System, etc.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
24	0	21

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	Yes

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
2.5MG	**	**	-	-	5
5MG	**	**	-	8	-
10MG	**	**	-	7	3
20MG	**	**	-	-	11
50MG	**	**	-	-	6

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	19

Manufacturing Details of DELTASONE